Humacyte, Inc. (NASDAQ:HUMA) Q2 2025 Earnings Call Transcript August 11, 2025
Humacyte, Inc. misses on earnings expectations. Reported EPS is $-0.24 EPS, expectations were $-0.15.
Operator: Good morning, ladies and gentlemen, and welcome to the Humacyte Second Quarter 2025 Results Conference Call. [Operator Instructions] As a reminder, this conference is being recorded. I would now like to turn the call over to Tom Johnson with Lifesci Advisors. Please go ahead.
Thomas Johnson: Thank you,...
